Invasive Salmonella infections in adults are commonly treated with fluoroquinolones, a critically important antimicrobial class. Historically, quinolone resistance was the result of chromosomal mutations, but plasmid-mediated quinolone resistance (PMQR) has emerged and is increasingly being reported in Enterobacteriaceae worldwide. PMQR may facilitate the spread of quinolone resistance, lead to higher-level quinolone resistance, and make infections harder to treat. To better understand the epidemiology of PMQR in non-typhoidal Salmonella causing human infections in the United States, we looked at trends in quinolone resistance among isolates submitted to the Centers for Disease Control and Prevention. We reviewed demographic, exposure and outcome information for patients with isolates having a PMQR-associated phenotype during 2008-2014 and tested isolates for quinolone resistance mechanisms. We found that PMQR is emerging among non-typhoidal Salmonella causing human infections in the United States and that international travel, reptile and amphibian exposure, and food are likely sources of human infection.
| INTRODUC TI ON
Quinolones constitute a critically important class of antibacterial drugs (World Health Organization, 2017) . The initial member of the class, nalidixic acid, had limited clinical use. Chemical modifications, including the addition of fluorine, yielded fluoroquinolones. Fluoroquinolones (e.g., ciprofloxacin, levofloxacin) have greater potency, broader spectra of activity, improved pharmacokinetics and a lower frequency of resistance development (Hooper & Jacoby, 2015) . Fluoroquinolones have been widely used to treat various infections (Yanat, Rodríguez-Martínez, & Touati, 2017) , including invasive non-typhoidal Salmonella infections, which can be life-threatening (Crump, Barrett, Nelson, & Angulo, 2003) . They have also been used in animals to prevent, control and treat infections (Food and Drug Administration (n.d.); Yanat et al., 2017) . Since quinolones were introduced into human and veterinary medicine, resistance to them has emerged and increased (Van, Nguyen, Smooker, & Coloe, 2012; Yanat et al., 2017) .
Fluoroquinolones target two essential bacterial enzymes, DNA gyrase and topoisomerase IV. In Enterobacteriaceae including Salmonella, quinolone resistance typically develops from the accumulation of chromosomal mutations in the quinolone resistance-determining region (QRDR) of target enzyme genes, primarily gyrA and parC (Cavaco & Aarestrup, 2009; Yanat et al., 2017) ; one mutation generally mediates resistance to nalidixic acid and decreases susceptibility to fluoroquinolones, while additional mutations lead to full fluoroquinolone resistance (Aarestrup, Wiuff, Mølbak, & Threlfall, 2003) . Since the late 1990s, three types of plasmid-mediated quinolone resistance (PMQR) mechanisms have been identified: qnr genes, which protect target enzymes; aac(6′)-Ib-cr gene, which mediates acetylation of certain quinolones; and oqxAB and qepA genes, which produce mobile efflux pumps (Jacoby, Strahilevitz, & Hooper, 2014) . A PMQR gene alone usually confers decreased susceptibility to fluoroquinolones and has less effect on nalidixic acid susceptibility (Hooper & Jacoby, 2015; Rodríguez-Martínez et al., 2016) . PMQR genes are particularly frequent among Enterobacteriaceae with decreased susceptibility to fluoroquinolones combined with nalidixic acid susceptibility (Rodríguez-Martínez et al., 2016) ; consequently, this phenotype is a clue to the presence of PMQR (Hooper & Jacoby, 2015) . During the last decade, PMQR has been increasingly reported in Enterobacteriaceae worldwide (Yanat et al., 2017) .
Plasmid-mediated quinolone resistance has important implications for the treatment of infections and the dissemination of antimicrobial resistance. Plasmids harbouring quinolone resistance genes can be transferred horizontally to other bacteria, thus spreading resistance. These plasmids often encode resistance to additional drug classes, especially cephalosporins (also used for treating salmonellosis). When this occurs, use of a single drug can co-select for resistance to drugs in multiple antimicrobial classes (Gay et al., 2006; . While PMQR genes generally cause increases in fluoroquinolone minimum inhibitory concentrations (MICs) that are below the resistance breakpoint, they may facilitate the emergence of higher-level quinolone resistance by increasing the mutant prevention concentration (lowest concentration of drug needed to prevent the growth of quinolone-resistant mutants) and by acting additively or synergistically with other quinolone resistance mechanisms (Jacoby et al., 2014; Lin, Chen, Wai-Chi Chan, & Chen, 2015; Robicsek et al., 2006) . The number of resistance mechanisms (QRDR mutations or PMQR genes) is correlated with ciprofloxacin MICs (Rodríguez-Martínez et al., 2016) . Studies suggest that even small increases in quinolone MICs can adversely impact response to treatment (Crump et al., 2003; Humphries, Fang, Aarestrup, & Hindler, 2012; Rodríguez-Martínez et al., 2016) .
In the United States, the National Antimicrobial Resistance Monitoring System (NARMS) tracks resistance among Salmonella and other enteric bacteria from humans, retail meat, and food animals. In a series of NARMS studies, PMQR was detected in 34 non-typhoidal Salmonella strains isolated from humans during 1996-2007, and a higher proportion of isolates were found to have PMQR in 2004 (Sjölund-Karlsson et al., 2009 (Sjölund-Karlsson et al., 2010 ) than in 1996 (Gay et al., 2006 . In 2015, NARMS reported an increase in the proportion of ciprofloxacin-non-susceptible isolates lacking nalidixic acid resistance (Centers for Disease Control & Prevention, 2015) , a finding that suggests that PMQR is increasing. To better understand the epidemiology of PMQR among non-typhoidal Salmonella causing human infections in the United States, we analysed quinolone MIC data for isolates submitted to NARMS, reviewed demographic, exposure and outcome information for patients with Salmonella isolates with a PMQR-associated phenotype, and tested a sample of isolates for quinolone-resistance mechanisms. (1996-2002) or 20th (2003-2014) isolate received from clinical laboratories to NARMS for surveillance purposes. This frequency-based sampling included isolates from both sporadic and outbreak cases. Health departments submitted additional isolates to NARMS through enhanced testing of outbreak isolates; data for these isolates are reported separately in the results section.
| MATERIAL S AND ME THODS
Health departments serotyped isolates and performed pulsed-field gel electrophoresis (PFGE) using standardized methods (Ribot et al., 2006; Strockbine, Bopp, Fields, Kaper, & Nataro, 2015) . MICs were determined at CDC using broth microdilution (Sensititre 
| Definitions
We defined the study phenotype as ciprofloxacin MIC ≥ 0.25 µg/ml with nalidixic acid susceptibility. We used this phenotype to identify a group of isolates likely to have PMQR (Hopkins, Day, & Threlfall, 2008; Hopkins, Wootton, Day, & Threlfall, 2007; Veldman et al., 2011) so we could then genetically test those isolates and collect corresponding patient exposure and outcome data. We defined multidrug resistance (MDR) as resistance to ≥1 agent in ≥3 classes. Isolates resistant (MIC ≥ 1 µg/ml) or intermediate (MIC 0.12-0.5 µg/ml) to ciprofloxacin were considered ciprofloxacin non-susceptible. An outbreak was defined as ≥2 cases of similar illness associated with a common exposure.
Hereafter, the term Salmonella refers to non-typhoidal Salmonella.
Impacts
• Plasmid-mediated quinolone resistance (PMQR) is emerging among non-typhoidal Salmonella causing human infections in the United States.
• International travel, reptile and amphibian exposure, and food are likely sources of human infection with Salmonella having PMQR.
• PMQR may facilitate the spread of quinolone resistance, lead to higher level quinolone resistance and make infections harder to treat. 
| Data collection and analysis

| Detection of quinolone resistance mechanisms
The presence of PMQR genes and QRDR mutations was determined for a subset of study-phenotype isolates from the period 2008 through 2014 using polymerase chain reaction (PCR) and/or whole genome sequencing (WGS). PCR primers used for aac(6′)- Ib-cr, gyrA, oqxA, oqxB, parC, qepA, qnrA, qnrB, qnrC, qnrD were confirmed to be negative for these genes using read-based approaches. Reads were examined using ARIBA v0.1 (Hunt et al., 2017) and ResFinder and by mapping reads to a recently discovered qnrE gene (Albornoz et al., 2017) using CLC Genomics Workbench.
| RE SULTS
| Quinolone resistance trends and isolate characteristics
During 1996-2014, both ciprofloxacin non-susceptibility and nalidixic acid resistance increased among Salmonella surveillance isolates; they Salmonella surveillance isolates were ciprofloxacin non-susceptible and 24% (117/489) of these isolates had the study phenotype. Enteritidis, Typhimurium and Newport were the most common Salmonella serotypes overall and the ones with the greatest number of ciprofloxacin-non-susceptible isolates during these years; 38% (186/489) of ciprofloxacin-non-susceptible isolates were serotype Enteritidis (Table 1 ). The proportion of ciprofloxacin-non-susceptible isolates with the study phenotype varied greatly by serotype; it was 1%, 32%, and 65% for serotypes Enteritidis, Typhimurium and Newport, respectively.
The 117 isolates with the study phenotype comprised 42 serotypes;
Typhimurium (17), Newport (13), Litchfield (9), Bareilly (8), Saintpaul (6), Corvallis (5) and Stanley (5) were most common and accounted for more than half of the isolates with the study phenotype. Most isolates with the study phenotype had a ciprofloxacin MIC of 0.5 µg/ml (72) 
| Patient exposures
Travel information was available for 81 (69%) of the 117 patients with study-phenotype isolates. Of these, 24 (30%) patients had a history of recent international travel before illness began; qnr genes were detected in all isolates from the travellers (Table 2) . Among 23 travellers with reported travel destinations, 14 (61%) travelled to Asia, six (26%) to Latin America or the Caribbean, and three (13%) to Africa.
Sixteen serotypes were identified among the 24 traveller isolates;
Typhimurium was the most common. Isolates from the 14 travellers to Asia had qnrS (10), qnrA (2), and qnrB (2) genes; the most common serotypes among these isolates were Stanley (3), Typhimurium 
| Enhanced outbreak isolate testing
We identified two additional foodborne outbreaks with study-phenotype isolates by reviewing antimicrobial susceptibility results for isolates submitted to CDC through enhanced testing of outbreak iso- 
| D ISCUSS I ON
Plasmid-mediated quinolone resistance is emerging among Salmonella causing human infections in the United States. We detected PMQR genes in 68 Salmonella isolates from humans comprising 34 serotypes. Our analysis indicates that infections with Salmonella harbouring PMQR genes were acquired both internationally and domestically. Likely sources of domestically acquired infections were reptile and amphibian exposure and food.
International travel before illness onset has been reported in 9%
of persons with laboratory-confirmed non-typhoidal Salmonella infections in the United States (Kendall et al., 2012) . It has also been reported as a source of infection with Salmonella having PMQR, particularly travel to Asia (Hopkins et al., 2008 (Hopkins et al., , 2007 Murray, Mather, Coia, & Brown, 2008; Sjölund-Karlsson et al., 2009 . In our study, 30% of patients with travel information and study-phenotype isolates travelled abroad, mostly to Asia. Although we cannot confirm that all 24 patients in our study with reported international travel were infected abroad, many of the infections were caused by serotypes that are uncommon in the United States, but common in of all sporadic Salmonella infections to reptile or amphibian contact (Mermin et al., 2004) . All patients in our study who reported reptile or amphibian exposure had isolates with PMQR genes and most of these isolates had serotypes that are reptile associated (Ackman, Drabkin, Birkhead, & Cieslak, 1995; Editorial Team et al., 2008; Guerra et al., 2010; Whitten, Bender, Smith, Leano, & Scheftel, 2015) ; these included several serotypes (e.g., Apapa, Telelkebir, IV 44:z4,z23:-) that are uncommon in humans (Centers for Disease Control & Prevention, 2017) . Three Salmonella Litchfield isolates from these patients were ciprofloxacin resistant and were the only study isolates tested with >1 PMQR gene detected, consistent with reports of higher-level quinolone resistance in strains carrying two or more unrelated PMQR genes (Jacoby et al., 2014; Lin et al., 2015; Rodríguez-Martínez et al., 2016) .
Plasmid-mediated quinolone resistance has been reported in Salmonella (Guerra et al., 2010; Veldman et al., 2011) 
and other
Enterobacteriaceae (Ahmed et al., 2007; Cortés-Cortés et al., 2016; Unger et al., 2017) from reptiles outside the United States.
Interestingly, a study of Salmonella strains isolated from reptiles in
Germany detected both qnrB and aac(6′)-Ib-cr genes in a Salmonella
Litchfield turtle isolate that had a ciprofloxacin MIC of 1 µg/ml and resistance to trimethoprim-sulfamethoxazole and tetracycline (Guerra et al., 2010) , like three Litchfield isolates from patients with reptile exposure in our study. More recently, other researchers in
Germany reported identifying a number of resistance genes, including qnrS1, mcr-1, bla CTX-M-55 , and mph(A) in MDR Escherichia coli
isolates from lizards imported from Vietnam (Unger et al., 2017) .
Reptiles and amphibians may acquire resistant bacteria from their environment, food or water sources, or other animals, and use of antimicrobial agents in these animals may select for resistant strains.
In Louisiana, high-level plasmid-mediated gentamicin resistance was found in Salmonella, E. coli and other bacteria isolated from pet turtle farms that attempted to eradicate Salmonella using gentamicin (Díaz, Cooper, Cloeckaert, & Siebeling, 2006) .
We retrospectively identified PMQR in three foodborne salmonellosis outbreaks and one sporadic infection that was likely acquired from contact with an ill foal. PMQR genes have been found in Salmonella and other bacteria from a variety of animals (wild and domestic) and foods in many countries (Ahmed et al., 2007; Jacoby et al., 2014; Lin et al., 2015; Rodríguez-Martínez et al., 2016; Veldman et al., 2011; Yanat et al., 2017) The Salmonella I 4, [5] ,12:i:-and Berta isolates with no PMQR genes detected had ciprofloxacin MICs ≤ 0.015 µg/ml upon retesting, while the Enteritidis and Ituri isolates with no PMQR genes detected had gyrA mutations; the Ituri isolate also had a parC mutation.
f Includes 13 Infantis, 12 Kentucky, 8 Choleraesuis, 5 Dublin, 2 Albert, 2 Nitra, 2 Oranienburg, 2 Potsdam, 2
Schwarzengrund, 1 I 6,7:r:-, 1 IIIa 50:z4,z23:-, 1 Bredeney, 1 Cubana, 1 Grumpensis, 1 Indiana, 1 London, 1 Oslo, 1 Poona. humans (Karp et al., 2017) .
We identified two study-phenotype isolates with a rare gyrA mutation (Gly81Asp) reported to confer greater resistance to fluoroquinolones than to nalidixic acid, unlike most QRDR mutations (Cattoir et al., 2006; Hopkins, Davies, & Threlfall, 2005) ; one of these isolates also had a parC mutation (Ser80Arg). A French study reported the co-occurrence of these two mutations in a clinical E. coli isolate from a patient treated with ofloxacin; the isolate had a ciprofloxacin MIC of 1 µg/ml and nalidixic acid susceptibility (Cattoir et al., 2006) , similar to a Salmonella Ituri isolate with the same mutations in our study.
Our study has several limitations. We did not capture all isolates with PMQR because we excluded isolates with nalidixic acid resistance and those with a ciprofloxacin MIC ≤ 0.12 µg/ml, which could harbour PMQR genes. prevalence of PMQR as those tested. We also did not perform susceptibility testing at the same time as WGS and PCR. Plasmid loss likely occurred in two isolates with no quinolone-resistance mechanisms detected; they had the study phenotype upon initial but not subsequent testing. Additionally, our study was descriptive and did not include a comparison group. We relied on patient information previously collected by health departments, and exposure and outcome information was incomplete. Information on reptile and amphibian exposures was more complete in later years.
The emergence of PMQR among Salmonella in the United States is of public health concern because it has the potential to spread rapidly, lead to high-level quinolone resistance, and make infections harder to treat (Gay et al., 2006; Jacoby et al., 2014; . Moreover, PMQR genes are often located on transferable plasmids with other resistance determinants and use of a single drug can select for MDR strains (Gay et al., 2006; Robicsek et al., 2006) . 
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